CRI Homepage > Resources & Publications > News & Reports > E-Newsletter > Cancer ImmuNews (2:3) November 2009
|
|
|
IN THIS ISSUE Focus on Prostate Cancer
QUICK LINKS CRI Homepage
Donate to CRI
Contact Us
Subscribe to Cancer ImmuNews
GIVE WISELY CRI consistently earns top marks from leading charity watchdogs. SHARE CRI's STORY
Help the cause by forwarding this email to three of your friends. Be sure to tell them why you support our work. SHOP + SEARCH = SUPPORT CRI
 STAY IN THE KNOW
Subscribe to our other free channels to get CRI updates & cancer news:   
Thank you for your support.
|
Skip Lockwood, CEO of ZERO - The Project to End Prostate Cancer, is seeing great strides being made by ZERO's efforts to reach men all across America. There's no debating the importance of educating men about their health and providing them with a way to take action.
|
Prostate cancer is the second leading cause of cancer-related deaths in men. In 2009, more than 27,000 men in the United States will fall victim to this disease. However, there is cause for hope: if prostate cancer is detected early and treated, survival rates can approach 100 percent.
CRI investigator Padmanee Sharma, M.D., Ph.D., describes her clinical trials in prostate cancer and the challenges to vaccination against the disease. Immunotherapies for Prostate Cancer >>
|
| |
Upcoming Events & Other Important Dates
|
 Dec. 31 - Last day for end-of-year giving
Mar. 1 - Investigator Award Application Deadline
Apr. 25 - Through the Kitchen 2010
|
|
| Forward this message to a friend | Phone: (212) 688-7515 or Toll-free (800) 99-CANCER |